Actelion Ltd. - redOrbit

Actelion Pharmaceuticals Takes to the Cloud with Global Deployment of Veeva CRM and iRep

2011-12-01 00:00:00

BARCELONA, Spain, December 1, 2011 /PRNewswire/ -- Multiple client/server SFA systems worldwide replaced by single cloud-based

GeneraMedix, Inc. Announces Sale of Innovative Epoprostenol Formulation to Actelion Ltd.

2009-02-23 09:00:00

LIBERTY CORNER, N.J., Feb. 23 /PRNewswire/ -- GeneraMedix, Inc.

Actelion Enters Phase III With Novel Orexin Receptor Antagonist Almorexant

2007-12-20 12:00:00

ALLSCHWIL, Switzerland, Dec. 20, 2007 (PRIME NEWSW

Phase III Study Initiated With Actelion-1 -- Highly Potent Tissue-Targeting Endothelin Receptor Antagonist; Largest Study Ever in PAH to Demonstrate Morbidity/Mortality Benefits

2007-12-19 12:00:13

ALLSCHWIL, Switzerland, Dec. 19, 2007 (PRIME NEWSWIRE) -- Actelion Ltd.

Actelion/Merck & Co., Inc. Renin Alliance Achieves Fourth Milestone -- Dosing in Phase II Initiated -- Actelion Receives USD10 Million

2007-12-05 12:00:13

ALLSCHWIL, Switzerland, Dec. 5, 2007 (PRIME NEWSWIRE) -- Actelion Ltd. (SWX:ATLN) announced today that the renin alliance with Merck & Co., Inc. has achieved its fourth milestone. The alliance has started dosing in the Phase II program for its first compound, a new renin inhibitor.

News - Actelion Ltd.

Breaking News

Streaming Video

Images and Photos

Space Exploration

Science and Research

Technology

My Health